Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy

Rheumatology

Volumn 48, Issue 5, 2009, Pages 569-572

  Lindsay, Karen ^a,d   Fraser, Alexander D ^b   Layton, Alison ^a   Goodfield, Mark ^b   Gruss, Hans ^c   Gough, Andrew ^a  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c Norgine Limited International   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Liver biopsy; Liver fibrosis; Methotrexate therapy; Psoriasis; Psoriatic arthritis; Safety incidence

Indexed keywords

FOLIC ACID; METHOTREXATE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ARTICLE; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR;

ADULT; AGED; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; BIOPSY; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; METHOTREXATE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; PSORIASIS; RISK FACTORS;

EID: 65249171604     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep023     Document Type: Article

References (19)

1. Zachariae H, Sogaard H, Heickendorff L. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies-a further 10-year follow-up. Dermatology 1996;192:343-6.
2. Kremer JM, Alarcon GS, Lightfoot RW Jr et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994;37:316-28.
3. Gilbert SC, Klintmalm G, Menter A, Silverman A. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent. Arch Intern Med 1990; 150:889-91.
4. West SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am 1997;23:883-915.
5. Langman G, Hall PM, Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol 2001;16:1395-401.
6. Roenigk HH Jr, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Methotrexate in psoriasis: Consensus conference. J Am Acad Dermatol 1998;38:478-85.
7. Whiting-O'Keefe QE, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: A meta-analysis. Am J Med 1991;90:711-16.
8. Grismer LE, Gill SA, Harris MD. Liver biopsy in psoriatic arthritis to detect methotrexate hepatotoxicity. J Clin Rheumatol 2001;7:224-7.
9. Lindsay K, Gough A. Psoriatic arthritis, methotrexate and the liver-are rheumatologists putting their patients at risk? Rheumatology 2008;47:939-41.
10. Afdhal NH, Nunes D. Evaluation of liver fibrosis: A concise review. Am J Gastroenterol 2004;99:1160-74.
11. Mofrad P, Contos MJ, Haque M et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
12. Guha IN, Rosenberg WM. Noninvasive assessment of liver fibrosis: Serum markers, imaging, and other modalities. Clin Liver Dis 2008;12:883-900.
13. Laharie D, Terrebonne E, Vergniol J et al. [The liver and methotrexate]. Gastroenterol Clin Biol 2008;32:134-42.
14. Zachariae H, Heickendorff L, Sogaard H. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: A 10-year follow-up. Br J Dermatol 2001;144:100-3.
15. Zachariae H, Aslam HM, Bjerring P, Sogaard H, Zachariae E, Heickendorff L. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: Relation to liver fibrosis and arthritis. J Am Acad Dermatol 1991; 25:50-3.
16. Weinblatt ME, Tesser JR, Gilliam JH 3rd. The liver in rheumatic diseases. Semin Arthritis Rheum 1982;11:399-405.
17. Walker AM, Funch D, Dreyer NA et al. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 1993;36:329-35.
18. van Ede AE, Laan RF, Rood MJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001;44:1515-24.
19. Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: A systematic review. Br J Dermatol. Advance Access published October 20, 2008, doi:10.1111/j.1365-2133. 2008.08876.x.